May is Skin Cancer Awareness Month — a period dedicated to educating people about early skin cancer detection and prevention.
Skin cancer is one of the most common cancers worldwide. It can be classified as melanoma and non-melanoma – non-melanoma skin cancer (NMSC) can also be further separated as basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) based on the type of cell in which the cancer originates. Melanoma is a cancer that develops in the skin’s melanocytes, or the skin cells located near the bottom layer of the epidermis that produce melanin. Skin cancer can occur when skin is damaged by sun rays or other sources of ultraviolet radiation, such as tanning equipment.
A history of severe sunburn can increase skin cancer risk. Other risk factors include family history, chemical exposure, and immunodeficiency.
Skin cancer is common but highly preventable through proper sun safety – raising awareness can prevent it and help reduce its incidence.
In Saudi Arabia, a study of 9,828 cases from 2007 to 2018 showed that 111 patients had skin cancer. The majority of cases were basal cell carcinoma with a total number of 76 (68.5%) of all cases. 18 patients (16.2%) were diagnosed with MSC. The remaining 17 patients (15.3%) were diagnosed with squamous cell carcinoma.
Another recent study showed that the incidence of non-melanoma skin cancer in Saudi Arabia lies between 3.4 and 4.4 per 100,000 people.
There are three main types of skin cancer — melanoma, basal cell carcinoma, and squamous cell carcinoma. Other less common types include Merkel cell skin cancer, skin lymphoma, Kaposi sarcoma, and non-melanoma skin cancer.
Here are some common skin cancer signs and symptoms to watch out for.
It forms on skin exposed to the sun. Symptoms include:
It appears as firm pink or red nodules. It can also develop as a rough, scaly, or itchy lesion or sore that may bleed or become crusty.
Melanoma can form anywhere, including the eyes and internal organs, and spread to other body parts. It can appear as an irregular brown patch or bump. A mole that bleeds or changes in size or color can be a melanoma. Dark lesions on mucous membranes or skin may also indicate melanoma.
Non-melanoma skin cancer appears as small, scaly, tan, or red spots on skin exposed to the sun.
In 2021, a study conducted with 529 participants from Saudi Arabia showed that about 55 percent were aware of skin cancer and its symptoms. However, 44 percent of participants were unaware of the types of skin cancer.
Skin cancer awareness is increasing worldwide. However, more awareness campaigns are required to highlight sun protection measures, preventive care, and early screening.
Here are some steps you can follow:
Skin cancer screening is suggested for high-risk individuals. However, patients can consult dermatologists or conduct self-exams. To promote this, in Saudi Arabia, the government holds national screening programs to detect chronic illnesses like cancer.
If a patient notices symptoms or the ABCDEs of skin cancer, screening and testing must be done immediately.
Join the MDBriefCase community for free to explore more courses.
199 Bay Street #4000, Toronto,
ON M5L 1A9
In submitting your work (the “Work”) for potential posting on the MDBriefCase Healthcare Leadership Academy website (the “Website”), you (“You”) expressly agree to the following:
Review: MDBriefCase is pleased to consider the publication of Your Work on the Website. The suitability of the Work for posting shall be determined by MDBRiefCase at its sole discretion. Nothing herein shall obligate MDBriefcase to post or otherwise publish the Work, or the maintain its posting in future.
Editing; Identification: MDBriefcase shall have the right to edit the Work to conform to our standards of style, technological requirements, language usage, grammar and punctuation, provided that the meaning of the Work is not materially altered. If posted, You will be identified as the author of the Work, or co-author if applicable.
Grant of Rights: As a condition of publication and for no monetary compensation, You hereby grant to MDBriefCase the following rights to the Work in any and all media whether now existing or hereafter developed, including print and electronic/digital formats: (1) the exclusive right of first publication worldwide; (2) the perpetual non-exclusive worldwide right to publish, reproduce, distribute, sell, adapt, perform, display, sublicense, and create derivative works, alone or in conjunction with other materials; (3) the perpetual non-exclusive worldwide right to use the Work, or any part thereof, in any other publication produced by MDBriefCase and/or on MDBriefCase’s website; and (4) the perpetual non-exclusive worldwide right to use the Work to promote and publicize MDBriefCase or its publications. The grant of rights survives termination or expiration of this Agreement.
Warranty: You warrant that the Work is original with You and that it is not subject to any third party copyright; that You have authority to grant the rights in this Agreement; that publication of the Work will not libel anyone or infringe on or invade the rights of others; that You have full power and authority to enter into this Agreement; that the Work has not been published elsewhere in whole or in part; and that You have obtained permission from the copyright owner consistent with this Agreement for any third party copyrighted material in the Work. This warranty survives termination or expiration of this Agreement.
Thank you for your interest in writing an article for the MDBriefCase Healthcare Leadership Academy website.
The Healthcare Leadership Academy welcomes submissions on all topics relevant to leaders in healthcare. Our topics include Leading in Healthcare, Leadership Lessons from COVID-19 and others. We prioritize stories that provide leadership advice to executives and managers in healthcare companies, offer actionable strategies for executing successful projects, and provide interesting angles on current healthcare topics. Submissions must be original work of the authors and unpublished. When submitting, authors represent that they have included no material that is in violation of the rights of any other person or entity.
Articles must be educational and non-promotional. If they mention the author’s company or any of the company’s products or services by name within the text, such mention should be very limited and used for reference only, not for promotion. (For example, an author might cite a survey conducted by his company but not describe his company’s product as a solution to a business problem.) Articles will be edited for clarity, style and brevity. The final headline is determined by the editor.
Guest articles for the MDBriefCase Healthcare Leadership Academy may run between 500 and 1000 words.
MDBriefCase reserves the right to accept or reject any submission and the right to condition acceptance upon revision of material to conform to its criteria.
There is no payment for contributed articles. However, MDBriefCase will give the author a byline. Authors are invited to link to the article on personal websites, corporate websites and social media platforms.
Each author understands and agrees that any submission accepted for posting is provided subject to MDBriefCase’s Author Agreement.
